all report title image

PEGFILGRASTIM BIOSIMILARS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Pegfilgrastim Biosimilars Market, By Product (Pegfilgrastim Biosimilars and Pegfilgrastim Reference Product), By Application (Oncology, Chronic Neutropenia, Stem Cell Transplantation, Others), By Route of Administration (Subcutaneous and Intravenous), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Aug 2024
  • Code : CMI7242
  • Pages :165
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Regional Analysis

Pegfilgrastim Biosimilars Market Regional Insights

To learn more about this report, request sample copy

North America dominates the global pegfilgrastim biosimilars market with an estimated market share of 41.3% in 2024. The U.S. market alone accounts for over 40% share due to huge demand for biosimilars from healthcare facilities as well as favorable reimbursement policies promoting their usage over reference biologics. Furthermore, presence of large regional pharmaceutical companies with established manufacturing and distribution networks aids product accessibility. While Canada also contributes significantly, future growth may be tempered by pricing pressures from government payers.

Asia Pacific region has emerged as the fastest growing market for pegfilgrastim biosimilars globally over the past few years. Countries such as China, India, South Korea and Japan are witnessing increasing adoption due to growing cancer patient pools as well as massive investments by both domestic and multinational companies to expand local manufacturing capabilities. This ensures reliable and affordable supply to meet domestic treatment needs. The Chinese market exhibit double digit expansion annually with government impetus on developing a strong biosimilars industry under the “Made in China 2025” program.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.